Improving diagnosis of acute febrile illness in Peru
GH20-005, Conducting Integrated Infectious Disease and Public Health Research in Peru
This study is working to improve how we diagnose fevers caused by infections in Peru by using new technology to find out what germs are making people sick, so we can better respond to these illnesses and keep everyone healthier.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10912422 on NIH RePORTER |
What this research studies
This research focuses on enhancing the diagnosis of acute febrile illness (AFI) in Peru by implementing advanced diagnostic technologies in areas with high rates of these illnesses. The project aims to establish year-round surveillance to detect over 30 pathogens that cause AFI, utilizing a method called the TaqMan array card. By understanding the diverse causes of AFI in different environmental contexts, the research seeks to improve public health responses and inform health policies. The ultimate goal is to enhance regional diagnostic capabilities and ensure that research findings are effectively translated into practice.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals in Peru experiencing symptoms of acute febrile illness, particularly in urban, riverine, and agricultural areas.
Not a fit: Patients outside of Peru or those not experiencing acute febrile illness may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses of acute febrile illnesses, improving treatment and public health responses in affected regions.
How similar studies have performed: Previous research has shown that implementing advanced diagnostic technologies in endemic regions can significantly improve disease detection and public health outcomes.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Kosek, Margaret N — University of Virginia
- Study coordinator: Kosek, Margaret N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.